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Spinal cord (SC) atrophy, i.e. a reduction in the SC cross-sectional area (CSA) over time, can be measured by
means of image segmentation using magnetic resonance imaging (MRI). However, segmentation methods
have been limited by factors relating to reproducibility or sensitivity to change. The purpose of this study was
to evaluate a fully automated SC segmentation method (PropSeg), and compare this to a semi-automated active
surface (AS)method, in healthy controls (HC) and peoplewithmultiple sclerosis (MS).MRI data from120 people
were retrospectively analysed; 26 HC, 21with clinically isolated syndrome, 26 relapsing remittingMS, 26 prima-
ry and 21 secondary progressive MS. MRI data from 40 people returning after one year were also analysed. CSA
measurements were obtained within the cervical SC. Reproducibility of the measurements was assessed using
the intraclass correlation coefﬁcient (ICC). A comparison between mean CSA changes obtained with the two
methods over time was performed using multivariate structural equation regression models. Associations
between CSA measures and clinical scores were investigated using linear regression models. Compared to the
ASmethod, the reproducibility of CSA measurements obtained with PropSeg was high, both in patients and in
HC, with ICC N 0.98 in all cases. There was no signiﬁcant difference between PropSeg and AS in terms of detecting
change over time. Furthermore, PropSeg providedmeasures that correlatedwith physical disability, similar to the
ASmethod. PropSeg is a time-efﬁcient and reliable segmentationmethod,which requires nomanual intervention,
and may facilitate large multi-centre neuroprotective trials in progressive MS.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Neuropathological and magnetic resonance imaging (MRI) studies
have demonstrated the involvement of the spinal cord (SC) in multiple
sclerosis (MS); neurodegeneration in the SC is thought to represent
the main pathological substrate of irreversible locomotor disability
(Abdel-Aziz et al., 2015; DeLuca et al., 2006; Ganter et al., 1999). In par-
ticular, SC MRI has provided indirect evidence of axonal degeneration
by quantifying atrophy, i.e. a reduction in SC cross-sectional area
(CSA) over time, with correlations identiﬁed between measures of
CSA and physical disability (Kearney et al., 2015b; Lin et al., 2004;
Losseff et al., 1996). Such associations support the notion that reliable
CSA estimation over time could be a plausible endpoint for clinical trials
for neuroprotection in MS (Kearney et al., 2014a), and a number of
exploratory studies have been reported in the literature (Kalkers et al.,
2002; Leary et al., 2003).
Previous methods used for measuring CSA have been variable in
terms of their reproducibility and sensitivity to small change, and all
of them require some degree of operator input (Coulon et al., 2002;
Horsﬁeld et al., 2010; Kawahara et al., 2013; Kidd et al., 1993; McIntosh
et al., 2011). Typically, intra- and inter-observer reproducibility is
assessed from repeated measurements by estimating the coefﬁcient of
variation (COV); the currently established semi-automated active surface
(AS) method offers intra- and inter-observer COV values of 0.44% and
1.07%, respectively (Horsﬁeld et al., 2010). More recently, investigators
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have aimed to develop fully automated segmentation methods, which
may minimize user-bias and signiﬁcantly reduce the image processing
time (Asman et al., 2014; Chen et al., 2013; Koh et al., 2011).
However, the variety of image acquisitions, the types of image con-
trast and variability of the ﬁeld of view (FOV) required for each speciﬁc
application, make it particularly challenging for each individual method
to simultaneously account for so many variables. A fully automated
method, called PropSeg, which accounts for such variability, has been
recently developed (De Leener et al., 2014). PropSeg is based on an
iterative propagation of a deformable model with adaptive contrast
mechanisms and offers fast and reliable measurements of the cord
CSA in a matter of seconds, as demonstrated in a pilot study of healthy
volunteers and people with spinal cord injury (De Leener et al., 2014);
importantly, the method has been reported to work when using T1-,
T2- and T2*-weighted acquisitions and at any level of the spinal cord.
In this study we evaluate PropSeg, as compared to the widely used
semi-automated AS method (Horsﬁeld et al., 2010), in a large cohort
of healthy controls and people with MS, in order to test the following
hypotheses:
(i) PropSeg provides reproducible CSAmeasurements in the cervical
SC.
(ii) A reduction in CSA in the cervical SC, seen longitudinally in MS,
can be reliably measured with PropSeg.
(iii) There are associations between cervical SC CSAmeasures derived
by PropSeg and clinical scores in MS.
2. Materials and methods
2.1. Study participants
MRI data from 120 peoplewere retrospectively analysed; 26 healthy
controls (HC), 21 people with clinically isolated syndrome (CIS), 26
relapsing remitting (RR) MS, 21 secondary progressive (SP) MS and
26primary progressive (PP)MS. The inclusion criteria for the CIS cohort,
and the criteria used for MS diagnosis and MS subgroup classiﬁcation,
have been reported previously (Kearney et al., 2014b, 2015a).
All people with CIS and MS had Expanded Disability Status Scale
(EDSS) (Kurtzke, 1983) and Multiple Sclerosis Functional Composite
(MSFC) score (Fischer et al., 1999) determined by the same neurostatus
certiﬁed assessor. Z-scores for the 25-foot timed walk test (TWT),
9-hole peg test (HPT) and 3 s paced auditory serial addition test B
(PASAT) were calculated using published normative values. For those
participants who could not perform the TWT and HPT, an arbitrary
value of 180 s or 300 s was assigned to that test, respectively. In addi-
tion, the American Spinal Injury Association (ASIA) motor (m) and
sensory (s) scores (Maynard et al., 1997) were recorded for all partici-
pants. All clinical assessments were performed immediately before
theMRI study. Demographic and clinical characteristics are summarised
in Table 1.
A total of 40 people returned for follow-up assessment, with MRI
and clinical assessments repeated at the second visit; 10 HC (4 female
(F), mean age (SD): 43.4 (8.9) years), 10 RRMS (6 F, 40.5 (9) years),
10 SPMS (4 F, 56.3 (5.9) years) and 10 PPMS (2 F, 56.2 (8.5) years).
The mean (SD) follow-up visit for the HC was (14 (5.2) months),
RRMS (24 (3.74) months), SPMS (16.3 (3.6) months) and PPMS (14.8
(4.9) months).
Informed written consent was obtained from each study participant
prior to inclusion in the study. The study received approval from the
local Institutional Ethics Committee.
2.2. MRI acquisition protocol
Imaging was performed using a 3 T Philips Achieva MRI system
with RF dual-transmit technology (Philips Medical Systems, Best,
Netherlands) and the manufacturer's product 16-channel neurovascular
coil.
The whole cervical cord was imaged using a magnetization-
prepared 3D T1-weighted acquisition (with isotropic voxel size of
1 mm3) in the sagittal plane with FOV = 256 × 256 mm2, matrix
size = 256 × 256, TR = 8 ms, TE = 3.7 ms, TI = 860 ms (using linear
k-space proﬁle order), SENSE = 2 in the anterior–posterior direction
and TFE factor of 205; the scan time for the acquisition was 6:30 min.
2.3. Image analysis
The 3D T1-weighted volume obtained from each study partici-
pant was processed using both the active surface (AS) (Horsﬁeld
et al., 2010) (Jim 6.0_019; http://www.xinapse.com/) and PropSeg
(De Leener et al., 2014) (Spinal Cord Toolbox version 1.0; https://
sourceforge.net/projects/spinalcordtoolbox/) segmentation methods
in two different ways, which provide the CSA at C2/C3 and between
C2 and C5, respectively: i) by reformatting the original sagittal vol-
ume in the axial plane and extracting 15 contiguous 1 mm thick
slices orthogonal to the longitudinal axis of the cervical cord centred
at the C2/C3 level – this was done using the multi-planar reconstruc-
tion option availablewithin Jim 6.0 that allows tomanually position the
handle of the reformatted volume orthogonal to the longitudinal axis of
the cervical cord centred at the C2/C3; the volume was subsequently
resampled using sinc interpolation along the slice direction – and ii)
by using the axial reformatted volume obtained from i), only this time
processing a larger number of axial slices to cover the section of the cer-
vical cord from the top of C2 to the base of C5 vertebral body as
Table 1
Demographic and clinical characteristics of study participants at baseline.
Controls
n = 26
CIS
n = 21
RRMS
n = 26
SPMS
n = 21
PPMS
n = 26
Gender (F:M) 17:9 13:8 17:9 12:9 11:15
Mean age (±SD) 42 (10.5) 35 (9) 40 (10) 51 (10) 51 (9)
Mean disease duration
(years/months for CIS)
N/A 5 7 19 10
Mean CSA (±SD) — PropSeg (C2/C3) 70.2 (7.4) 75.9 (7.9) 68.6 (7.7) 56.2 (10.1) 61.1 (9.3)
Mean CSA (±SD) — AS (C2/C3) 75.8 (7.7) 82.0 (8.2) 74.0 (7.3) 62.0 (10.5) 67.1 (10.6)
Mean CSA (±SD) — PropSeg (C2/C5) 72.4 (7.1) 77.9 (7.9) 71.3 (7.9) 58.2 (10.0) 62.5 (9.0)
Mean CSA (±SD) — AS (C2/C5) 78.7 (7.4) 84.7 (8.0) 77.5 (8.0) 64.4 (10.4) 69.8 (9.7)
Median EDSS (range) N/A 1 (0–3.5) 3 (0–6.5) 7 (4.5–7.5) 6 (2–7)
Median TWT (range) 5 (4–6) 4.6 (3.4–9.8) 5.7 (3.4–9.6) 22.3 (5–180) 8.3 (5–180)
Median HPT (range) 18.9 (15.1–27.1) 20.7 (16.6–25.4) 20.5 (15–36.4) 29.6 (19.1–200.8) 28.9 (17.1–179.6)
Mean PASAT (±SD) 53 (5.3) 45.2 (9.4) 41.6 (14.6) 37 (19.2) 34.9 (18.8)
Median ASIA-m (range) 100 (–) 100 (98–100) 99 (74–100) 87 (63–98) 85 (54–100)
Median ASIA-s (range) 112 (–) 112 (84–112) 110 (98–112) 104 (84–112) 101.5 (90–112)
CIS: clinically isolated syndrome; RRMS: relapsing remitting MS; PPMS: primary progressive MS; SPMS: secondary progressive MS; EDSS: expanded disability status score; TWT: 25-foot
timedwalk test; HPT: 9-hole peg test; PASAT: 3 s paced auditory serial addition test B; ASIA: American Spinal Injury Associationmotor (m) and sensory (s) scores; SD: standard deviation.
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previously reported (Horsﬁeld et al., 2010). The rationale for selecting
and processing these two segments of the cervical cord in this study is
based on previously published methods in MS, which were shown to
offer reproducible atrophy measurements and/or were used to investi-
gate the possibility that speciﬁc levels of the cervical cordwere particu-
larly sensitive to MS-related atrophy (Horsﬁeld et al., 2010; Kearney
et al., 2014a; Losseff et al., 1996; Rocca et al., 2011).
2.3.1. AS analysis method
Using theASmethod, each scanwas processed by a single rater (MY)
as follows: a seed point was ﬁrst placed in the centre of the cord on the
most superior axial slice in which the odontoid process of the axis (C2)
was still visible. The next seed point was placed in the centre of the cord
on the slice that passed through the inferior border of C5. Starting at C5
andmoving superiorly, a seed pointwas placed in the centre of the cord
on every tenth slice until the seed point at the top of C2 was reached
(Horsﬁeld et al., 2010) (see Fig. 1 A–C). In this way, the boundary of
the cord on all slices from C2 to C5 was identiﬁed and 15 slices corre-
sponding to the C2/C3 level were subsequently processed for method
i) and all the slices processed for method ii).
2.3.2. PropSeg analysis method
Using the PropSegmethod, all 3D T1-weighted volumes were proc-
essed in their original form (sagittal plane) taking only a few minutes
in total, simply by specifying the directory storing all the data. The proc-
essed volumes containing the binarymask of thewhole cervical SCwere
then reformatted in the axial plane to match the processing of the AS
method i.e. by extracting the equivalent slices as per i) and ii) described
earlier. Fig. 1 D–F shows an example of the result obtained using PropSeg
with the original sagittal volume and an example of a single axial
reformatted slice through the C2/C3 intervertebral disc showing the
cord contour identiﬁed using both PropSeg and AS segmentation
methods for comparison.
Whilst for i) an equal number of slices was processed in all cases,
the number of slices processed in ii) was not always the same due to
anatomical variability; for this reason, CSA measurements were nor-
malized by the number of slices as previously suggested (Healy
et al., 2012).
2.4. Statistics
Statistical analyses were performed using Stata 13.1 (Stata Corp.).
2.4.1. Reproducibility assessment
Since the PropSeg method inherently outputs the same result each
time the same scan is analysed, i.e. intra- and inter-observer reproduc-
ibility COV = 0%, the most appropriate test of reproducibility in this
case was related to the ability of each segmentation method to obtain
near-identical measurements when a number of the study participants
underwent the same MRI examination twice (i.e. ‘scan–rescan’ assess-
ment). For this purpose, 8 healthy controls (6 males, mean age 33.5,
SD 6.7) and 8 people with MS (5 females, mean age 43.3, SD 11.3, 4
RRMS, 4 SPMS) had the scan twice after being removed from the scan-
ner and repositioned between the scans during the same visit.
For the assessment of scan–rescan reproducibility, the intraclass
correlation coefﬁcient (ICC) was calculated and subsequently 1-ICC
was reported; 1-ICC provides an estimate of the fraction of variability
due to measurement error (within-subject) over the total variation,
i.e. biological variation (between-subject) and within-subject variation
(Bartlett and Frost, 2008). 95% conﬁdence intervals (CI) and p-values
were obtained using bias-corrected and accelerated non-parametric
bootstrap with 1000 replicates.
Fig. 1. (A–C) Segmentation of the cervical cord using the active surface (AS)method; seed points aremanually positioned in the centre of the cord to cover the C2/C5 level; also shown is an
example of a single axial reformatted slice through the C2/C3 intervertebral disc showing the cord contour identiﬁed using the ASmethod (contour shown in red). (D–F) Segmentation of
the cervical cord using the PropSegmethodwith the sagittal volume (contour shown in cyan); also shown is the same axial reformatted slice through the C2/C3 intervertebral disc showing
the cord contour identiﬁed using both the PropSeg (contour shown in cyan) and ASmethods (contour shown in red) for comparison. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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2.4.2. Change in CSA over time and effect size calculations
Mean changes in cord CSA over one year were investigated for each
participant group (apart from CIS), each cervical SC segment and each
segmentation method. For each group of participants and for each
cervical SC segment, a formal comparison between mean CSA changes
obtained with the two segmentation methods was performed using
multivariate (bivariate) structural equation regression models; in this
context these essentially ﬁt two regression models simultaneously,
allowing the comparison, across models, of relevant coefﬁcients.
To assess the potential usefulness of the CSA measure to detect
change, the change ratio (CR), the ratio of the mean of within-subject
changes/standard deviation (SD) of within-subject changes, was cal-
culated for each segmentation method, each cord segment, and each
group. This is because the sensitivity to change, or the power of a
method, is related not to the absolute magnitude of the change but
to the change relative to the SD of changes. To assess the potential
sensitivity to patient pathology, for each patient group, effect size
(ES) was calculated as the difference between the mean CSA change
in that patient group and the mean CSA change in the control group,
divided by the SD of the change in the patient group; again the mag-
nitude of the difference relative to SD is crucial. For both CR and ES
measures, higher values indicated a greater sensitivity and power
of the MRI measure to detect change or difference. MRI measures
with large CR denote that the individuals of a group show a homoge-
neously large amount of change over time relative to the ‘noise’. Similarly,
MRI measures with large ES would reﬂect a large and homogeneous
difference between the change in a given group of patients and that in
controls.
2.4.3. Associations between CSA measures and clinical scores
In order to investigate and compare associations between the
clinical and the two segmentation MRI measures, each baseline clinical
variable (for each cervical cord segment) was used as the response
(dependent) variable in linear regressionmodels,with the following ex-
planatory variables: i) baseline AS-derived CSA; ii) baseline PropSeg
CSA; iii) both AS and PropSeg baseline CSA. For each clinical variable, a
comparison was made between the R-square of the model in i) and
that of the model in ii). Models obtained in iii) were used to assess the
comparative potential of the two segmentation methods to explain
the variability of the clinical variable. Similar models were performed
using one-year MRI and one-year clinical measures, and using baseline
MRI and one year clinical measures. In this exploratory work, a number
of statistical tests were performed. However, these were in order to ex-
amine several null hypotheses as opposed to a single one; for this reason
adjustment for multiple comparisons was not made (Perneger, 1998).
Signiﬁcance level was set at 5%.
3. Results
Representative mean (SD) CSA measurements obtained at each cer-
vical SC level with each segmentation method and for each participant
group at baseline are shown in Table 1. Out of 160 scans processed in
total, PropSeg failed to correctly segment the cord only in 3 cases (1
healthy control and 2 RRMS), and these cases were manually processed
by inserting seed points in the centre of the cord prior to the segmenta-
tion; the presence of MS lesions had no obvious effect on the perfor-
mance of the segmentation method (see Fig. 2). Segmentation of the
cord using the ASmethod was successful in all cases.
3.1. Reproducibility assessment
In the HC group, the estimated ICC values for the C2/C3 and C2/C5
levels were very similar using both segmentation methods. In the
patient group, the estimated ICC values were slightly higher using the
AS method than PropSeg, for both cervical cord levels. Nevertheless,
the estimated ICC values were always above 0.98 (Table 2).
Fig. 2. A) The cervical cord in the sagittal plane showing a multiple sclerosis (MS) lesion (hypointense) at the C2 level in a case of secondary progressiveMS (SPMS), B) axial slice through
the level of the lesion at the C2 level, C) the cord contour identiﬁed using the ASmethod (contour shown in red) and D) the same axial slice through theMS lesion at C2 showing the cord
contour identiﬁed using both the PropSeg (contour shown in cyan) and ASmethods (contour shown in red) for comparison. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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3.2. Change in CSA over time and effect size calculations
For the C2/C3 level, mean changes measured using AS and PropSeg
methods were not signiﬁcantly different for any of the groups, except
for a borderline evidence of a higher (negative) change in RRMS using
PropSeg than AS (p = 0.0425).
For the C2/C5 level, in controls there was no evidence of any of the
changes over time, with either PropSeg or AS, being different from
zero. No differences were observed between methods for the other
groups.
As regards the CR of one-year change in CSA, apart from PPMS, CR
was slightly higher using PropSeg than AS and for both segments of
the cervical SC (Table 3); CSA reduction was greater in patients than
controls, although not statistically signiﬁcant.
The ES, for the C2/C3 level was better using PropSeg than AS, apart
from the PPMS group. Instead, for the C2/C5 level, PropSeg was worse
than AS in all patient groups (Table 4).
3.3. Associations between CSA measures and clinical scores
Univariable models showed that baseline CSA measures for both
segments of the SC were signiﬁcantly associated with baseline clinical
variables, for both segmentation methods (Table 5). At one-year
follow-up, CSA measures were only signiﬁcantly associated with ASIA-
m and ASIA-s, for both cervical SC segments (Table 6). Baseline CSA
measures for both segments predicted ASIA-m scores at one-year
follow-up, for PropSeg and ASmethods (for C2/C3: p = 0.001 and p =
0.003, respectively; for C2/C5: p b 0.001 and p = 0.001, respectively)
(Table 7).
Multiple regression models showed that baseline CSAmeasures ob-
tained with PropSegmethod were better at explaining the variability of
the EDSS andASIA-m (for the C2/C3 segment: p=0.085 and p=0.022,
respectively; for the C2/C5 segment: p = 0.049 and p = 0.048).
Additionally, baseline PropSeg measures at C2/C3 explained better the
variability of ASIA-s (p = 0.020) than ASmethod. At one-year follow-
up, there was no evidence that any of the methods was better than
the other at explaining the variability of any of the clinical measures.
As regards prediction analyses, there was borderline evidence of the
PropSeg method (C2/C5 measures at baseline) explaining better than
the AS method (also at baseline, C2/C5 measures) the variability of
ASIA-m at one-year follow-up.
4. Discussion
This is the ﬁrst study to apply a fully automatedmethod (PropSeg) of
spinal cord area measurement to people with MS. The results of this
study demonstrate that: ﬁrstly, PropSeg provides a reproducible mea-
surement of cord area both in healthy controls and peoplewithMS, sim-
ilarly to the widely used AS (Horsﬁeld et al., 2010); secondly, PropSeg
seems to be able to detect changes over time reliably, at least with the
same sensitivity as the ASmethod; thirdly, PropSeg provides cord area
measures that reﬂect physical disability, as shown by the presence of
signiﬁcant associations between obtained cord area values and physical
disability, aswell as being predictive of a speciﬁc measure of spinal cord
dysfunction (ASIA-m) at one-year follow-up.
This current study demonstrates that a fully automated software
package may be used to measure cord area in MS, acknowledging the
fact that only T1-weighted MRI was used in this particular study; the
use of any other type of contrast, or even the application of PropSeg to
other neurological conditions merit investigation in their own right.
As the software is automated, we chose to demonstrate its reproduc-
ibility by measuring the scan–rescan ICC, which was N0.98 for
two different segments of the cervical cord. This agrees strongly
with the AS measurements obtained in this current study and a pre-
vious study, that also measured its reproducibility (Kearney et al.,
2014a). Here, manual intervention was required to identify the ver-
tebral levels (i.e. slices corresponding to C2/C3 and C2/C5), to ensure
a direct comparison between the two segmentation methods. How-
ever, a new feature has recently been added to PropSeg that automat-
ically identiﬁes vertebral levels using template-based approaches,
allowing the user to prespecify the cord segment(s) of interest (De
Leener et al., in press). In conjunction with the probabilistic mapping
of spinal levels based on vertebral levels (Cadotte et al., 2015), such
information might provide more speciﬁc association between clini-
cal deﬁcits and the level of spinal cord atrophy, as shown in ALS
(Cohen-Adad et al., 2013).
In order to use cord atrophy as an endpoint for a clinical trial the
methodology must be sufﬁciently sensitive to a small reduction in
cord area. In the current study we have shown that the reductions in
cord area observed over one year, although not signiﬁcant, were in
line with the ASmethod, used as an anchor measure in this study. The
lack of signiﬁcant reduction may relate to the smaller number of pa-
tients followed up, which likely reduced the statistical power. The
high CR and ES values obtained with PropSeg further emphasise the ro-
bustness of this technique when applied to a longitudinal study of cord
atrophy in MS. However, the worse ES result observed at C2/C5 in all
groups using PropSeg could be additionally informative. Bearing in
mind the higher CR values of PropSeg as compared to AS at that level,
coupled with the slightly lower ICC values observed for both methods
at C2/C5 as compared to the C2/C3 level, this may be indicative of a re-
duced reliability of atrophy measurements when obtained at the C2/C5
level. The potential pitfalls of studying the C2/C5 level as opposed to
C2/C3 have been mentioned elsewhere (Kearney et al., 2014a; Losseff
et al., 1996; Reid, 1960) and the signiﬁcance and relative clinical impact
of the small variations in ICC, CR, and ES identiﬁed in this study have not
been examined speciﬁcally. Nevertheless, it has been shown that, at
least for the C2/C3 level, PropSeg provides reproducible measurements
Table 2
Intraclass correlation coefﬁcient (ICC) for scan–rescan reliability using PropSeg and AS seg-
mentation methods for measuring the cervical cord cross-sectional area (CSA) at the C2/
C3 and C2/C5 levels in healthy control (n = 8) and MS cases (n = 8).
ICC (95% CI)
Healthy controls C2/C3 C2/C5
CSA — PropSeg 0.992 (from 0.934 to 0.996) 0.990 (from 0.968 to 0.995)
CSA — AS 0.992 (from 0.977 to 0.995) 0.990 (from 0.973 to 0.994)
MS cases
CSA — PropSeg 0.984 (from 0.938 to 0.991) 0.985 (from 0.734 to 0.991)
CSA — AS 0.992 (from 0.86 to 0.996) 0.994 (from 0.862 to 0.997)
ICC: intraclass correlation coefﬁcient; CSA: cross-sectional area; CI: conﬁdence interval.
Table 3
Ratio of change (CR) in CSA measures over one year.
C2/C3 C2/C5
Group PropSeg AS PropSeg AS
Controls −0.365 −0.181 −0.337 0.081
RRMS −0.296 −0.116 −0.357 −0.217
SPMS −0.553 −0.417 −0.393 −0.189
PPMS −0.744 −0.883 −0.179 −0.205
RRMS: relapsing remittingMS; PPMS: primary progressiveMS; SPMS: secondary progres-
sive MS
Table 4
Effect size calculation.
C2/C3 C2/C5
Groups PropSeg AS PropSeg AS
RRMS (vs. controls) −0.2 −0.042 −0.195 −0.26
SPMS (vs. controls) −0.209 −0.171 0.067 −0.319
PPMS (vs. controls) −0.6 −0.707 −0.014 −0.292
RRMS: relapsing remittingMS; PPMS: primary progressiveMS; SPMS: secondary progres-
sive MS
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and can detect change with at least the same sensitivity as the AS
method.
Owing to the longitudinal nature of this present study we were also
able to examine the predictive ability of cord atrophy, in relation to
physical disability in MS. The spinal cord speciﬁc measure of motor
disability used in this study (ASIA-m) was predicted by cord atrophy
using the fully automated PropSegmethod. Importantly, as regards the
univariable models, the obtained R-squared were generally at least as
Table 5
Associations between CSA measures and clinical scores at baseline (unadjusted).
PropSeg AS
Regression coefﬁcient (95% CI), p-value R2 Regression coefﬁcient (95% CI), p-value R2
C2/C3 measures
EDSS −0.13 (−0.165 to−0.094), p b 0.001 0.366 −0.123 (−0.157 to−0.088), p b 0.001 0.347
TWT −1.652 (−2.417 to−0.886), p b 0.001 0.134 −1.612 (−2.354 to−0.87), p b 0.001 0.136
HPT −1.136 (−1.729 to−0.543), p b 0.001 0.109 −1.084 (−1.660 to−0.508), p b 0.001 0.105
PASAT 0.32 (0.059 to 0.581), p = 0.017 0.048 0.312 (0.059 to 0.566), p = 0.016 0.049
ASIA-m 0.533 (0.362 to 0.704), p b 0.001 0.244 0.492 (0.323 to 0.660), p b 0.001 0.22
ASIA-s 0.246 (0.133 to 0.359), p b 0.001 0.136 0.22 (0.109 to 0.331), p b 0.001 0.116
C2/C5 measures
EDSS −0.128 (−0.163 to− .093), p b 0.001 0.361 −0.122 (−0.157 to−0.087), p b 0.001 0.341
TWT −1.759 (−2.513 to−1.003), p b 0.001 0.153 −1.729 (−2.467 to−0.99), p b 0.001 0.154
HPT −1.153 (−1.743 to−0.562), p b 0.001 0.112 −1.096 (−1.675 to−0.516), p b 0.001 0.106
PASAT 0.344 (0.084 to 0.603), p = 0.010 0.056 0.315 (0.061 to 0.57), p = 0.016 0.049
ASIA-m 0.526 (0.355 to 0.698), p b 0.001 0.239 0.497 (0.328 to 0.667), p b 0.001 0.223
ASIA-s 0.24 (0.127 to 0.353), p b 0.001 0.131 0.225 (0.114 to 0.336), p b 0.001 0.12
EDSS: expanded disability status score; TWT: 25-foot timed walk test; HPT: 9-hole peg test; PASAT: 3 s paced auditory serial addition test B; ASIA: American Spinal Injury Association
motor (m) and sensory (s) scores; CI: conﬁdence interval.
Table 6
Associations between CSA measures and clinical scores at one-year follow-up (unadjusted).
PropSeg AS
Regression coefﬁcient (95% CI), p-value R2 Regression coefﬁcient (95% CI), p-value R2
C2/C3 measures
EDSS −0.030 (−0.01 to 0.039), p = 0.372 0.045 −0.032 (−0.09 to 0.028), p = 0.272 0.067
TWT −1.881 (−4.23 to 0.466), p = 0.113 0.113 −1.735 (−3.917 to 0.447), p = 0.115 0.073
HPT −1.514 (−3.168 to 0.14), p = 0.071 0.092 −1.291 (−2.842 to 0.26), p = 0.100 0.078
PASAT 0.216 (−0.507 to 0.94), p = 0.547 0.011 0.147 (−0.527 to 0.822), p = 0.660 0.006
ASIA-m 0.688 (0.287 to 1.09), p = 0.001 0.241 0.627 (0.246 to 1.01), p = 0.002 0.226
ASIA-s 0.23 (0.012 to 0.447), p = 0.039 0.107 0.207 (0.002 to 0.413), p = 0.048 0.099
C2/C5 measures
EDSS −0.028 (−0.093 to 0.038), p = 0.389 0.042 −0.03 (−0.091 to 0.03), p = 0.308 0.058
TWT −2.082 (−4.376 to 0.213), p = 0.074 0.094 −2.097 (−4.26 to 0.066), p = 0.057 0.106
HPT −1.478 (−3.097 to 0.141), p = 0.072 0.092 −1.39 (−2.91 to 0.136), p = 0.073 0.092
PASAT 0.234 (−0.473 to 0.941), p = 0.505 0.013 0.182 (−0.486 to 0.85), p = 0.584 0.009
ASIA-m 0.682 (0.287 to 1.077), p = 0.001 0.243 0.634 (0.257 to 1.01), p = 0.002 0.234
ASIA-s 0.255 (0.044 to 0.466), p = 0.019 0.137 0.228 (0.026 to 0.43), p = 0.028 0.121
EDSS: expanded disability status score; TWT: 25-foot timed walk test; HPT: 9-hole peg test; PASAT: 3 s paced auditory serial addition test B; ASIA: American Spinal Injury Association
motor (m) and sensory (s) scores; CI: conﬁdence interval.
Table 7
Independent predictors of clinical changes (unadjusted).
PropSeg AS
Regression coefﬁcient (95% CI), p-value R2 Regression coefﬁcient (95% CI), p-value R2
C2/C3 measures
EDSS −0.026 (−0.099 to 0.047), p = 0.459 0.031 −0.0302 (−0.09 to 0.029), p = 0.298 0.06
TWT −1.888 (−4.258 to 0.483), p = 0.115 0.074 −1.493 (−3.70 to 0.72), p = 0.178 0.054
HPT −1.491 (−3.151 to 0.168), p = 0.077 0.089 −1.163 (−2.72 to 0.398), p = 0.139 0.063
PASAT 0.243 (−0.481 to 0.966), p = 0.5 0.014 0.202 (−0.47 to 0.874), p = 0.546 0.011
ASIA-m 0.7 (0.288 to 1.113), p = 0.001 0.237 0.602 (0.212 to 0.991), p = 0.003 0.204
ASIA-s 0.161 (−0.07 to 0.390), p = 0.165 0.050 0.155 (−0.057 to 0.367), p = 0.147 0.055
C2/C5 measures
EDSS −0.024 (−0.096 to 0.0492), p = 0.505 0.025 −0.027 (−0.087 to 0.034), p = 0.371 0.045
TWT −2.183 (−4.503 to 0.137), p = 0.064 0.1 −2.035 (−4.199 to 0.13), p = 0.065 0.1
HPT −1.504 (−3.142 to 0.132), p = 0.070 0.093 −1.278 (−2.796 to 0.239), p = 0.096 0.079
PASAT 0.239 (−0.476 to 0.954), p = 0.501 0.013 0.173 (−0.487 to 0.833), p = 0.597 0.008
ASIA-m 0.752 (0.358 to 1.145), p b 0.001 0.282 0.645 (0.27 to 1.02), p = 0.001 0.242
ASIA-s 0.203 (−0.019 to 0.425), p = 0.073 0.082 0.192 (−0.014 to 0.397), p = 0.066 0.086
EDSS: expanded disability status score; TWT: 25-foot timed walk test; HPT: 9-hole peg test; PASAT: 3 s paced auditory serial addition test B; ASIA: American Spinal Injury Association
motor (m) and sensory (s) scores; CI: conﬁdence interval.
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high in the PropSeg method models as in the AS method models, and
several times higher in the clinical models using PropSeg measures.
However, more commonly used scales of physical disability in MS
(such as the EDSS and MSFC) were not predicted by either the PropSeg
method or the ASmethod.
4.1. Limitations and future directions
A number of limitations should be consideredwhen interpreting the
results of this study. Firstly, PropSeg has been evaluated inMS using only
T1-weighted images and therefore the performance of the method
using other forms of contrast in MS will need to be investigated specif-
ically. However, due to the time-efﬁcient and fully automated nature of
the method, such assessments may be easily carried out on retrospec-
tive data.
As previously mentioned, a subset only of the cohort included at
baselinewas followed up at one year. This could be addressed in a future
longitudinal study, in which a greater number of the baseline partici-
pants are followed up. One factor that may facilitate such a study
would be to include people with progressive MS that have lower levels
of physical disability, so that with time severe disability does not be-
come a prohibitive factor for scanning.
Furthermore, the followed-up cohort consisted of people with
different subgroups of MS. This may have conceivably inﬂuenced the
overall rate of atrophy observed, thereby inﬂuencing the predictive
power of this MRI parameter. A future longitudinal study containing,
either a single subgroup of MS, or a sufﬁciently large cohort, so that be-
tween group factors can be analysed would be of importance.
Lastly, the current study was performed on data acquired in a single
centre. Although the results obtained were in line with the hypotheses
being investigated, many clinical trials in MS are performed in multiple
centres and these hypotheses have not been tested in such a scenario. It
would therefore be of importance to determine the sensitivity to pathol-
ogy when introducing different scanner manufacturers as confounder
when using the PropSegmethod. This could be addressed by analysing
data from existing (or future) multi-centre trials in MS that include im-
aging of the spinal cord.
5. Conclusion
This study demonstrates that spinal cord atrophy may be measured
reliably in multiple sclerosis using a fully automated image segmenta-
tion method. These results have direct implications for future clinical
trials for neuroprotection in progressive MS, where previous attempts
at spinal cord atrophy measurement have been limited by factors
relating to reproducibility or sensitivity to change, both of which are
addressed in this study.
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